Cannabidiol soft-gel (Avecho Biotechnology)

N/A

Report date: 2025/03/12 20:00:47

Base Information

Drug NameCannabidiol soft-gel (Avecho Biotechnology)
Drug Alias NameCBD soft-gelCBD-TPM
ClassificationSmall molecules
Mechanisms of ActionCannabinoid CB1 receptor inverse agonistsCannabinoid CB2 receptor inverse agonistsSerotonin 5-HT1 receptors modulators +[4] 
TargetsCannabinoid CB1 receptorCannabinoid CB2 receptorSerotonin 5-HT1 receptors +[4] 
Therapy Area/IndicationsSleep Initiation and Maintenance Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAvecho Biotechnology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAvecho Biotechnology Ltd
Inactive CompaniesN/A
Active IndicationsSleep Initiation and Maintenance Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A